With its outstanding investment team and unique multimanager approach, Primecap Odyssey Growth is exemplary.
PRIMECAP Odyssey Growth POGRX
- NAV / 1-Day Return 38.52 / −0.18 %
- Total Assets 6.4 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.660%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.46%
- Turnover 7%
USD | NAV as of May 10, 2024 | 1-Day Return as of May 10, 2024, 10:12 PM GMT+0
Morningstar’s Analysis POGRX
Will POGRX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 9.01 | 615.0 Mil | Healthcare |
Dreyfus Treasury Secs Cash Mgmt Inst | 5.49 | 374.6 Mil | Corporate |
Micron Technology Inc | 3.20 | 218.8 Mil | Technology |
AECOM | 2.64 | 180.2 Mil | Industrials |
Raymond James Financial Inc | 2.50 | 170.4 Mil | Financial Services |
Microsoft Corp | 2.48 | 169.0 Mil | Technology |
Biogen Inc | 2.39 | 163.5 Mil | Healthcare |
KLA Corp | 2.23 | 152.5 Mil | Technology |
Amgen Inc | 2.16 | 147.3 Mil | Healthcare |
Biomarin Pharmaceutical Inc | 2.08 | 141.9 Mil | Healthcare |